Home Biotechnology CRISPR Technology Market

CRISPR Technology Market Size, Share & Trends Analysis Report By Product & Service (Product, Enzymes, Kits & Reagents, Guide RNA, CRISPR Libraries, Other Products, Service, gRNA Design & Synthesis, Cell Line Engineering, Animal Model Generation, CRISPR Screening Services, Other Services), By Technology (CRISPR/Cas9, CRISPR/Cas12, Base Editing, Prime Editing, Other Technologies), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research organization, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 29, 2026 | Author: Dhanashri B | Format: | Report Code: SRBI54553DR | Pages: 160

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global CRISPR Technology Market Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Product
        1. By Value
      3. Enzymes
        1. By Value
      4. Kits & Reagents
        1. By Value
      5. Guide RNA
        1. By Value
      6. CRISPR Libraries
        1. By Value
      7. Other Products
        1. By Value
      8. Service
        1. By Value
      9. gRNA Design & Synthesis
        1. By Value
      10. Cell Line Engineering
        1. By Value
      11. Animal Model Generation
        1. By Value
      12. CRISPR Screening Services
        1. By Value
      13. Other Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR/Cas9
        1. By Value
      3. CRISPR/Cas12
        1. By Value
      4. Base Editing
        1. By Value
      5. Prime Editing
        1. By Value
      6. Other Technologies
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. Contract Research organization
        1. By Value
      5. Other End Users
        1. By Value
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Product
        1. By Value
      3. Enzymes
        1. By Value
      4. Kits & Reagents
        1. By Value
      5. Guide RNA
        1. By Value
      6. CRISPR Libraries
        1. By Value
      7. Other Products
        1. By Value
      8. Service
        1. By Value
      9. gRNA Design & Synthesis
        1. By Value
      10. Cell Line Engineering
        1. By Value
      11. Animal Model Generation
        1. By Value
      12. CRISPR Screening Services
        1. By Value
      13. Other Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR/Cas9
        1. By Value
      3. CRISPR/Cas12
        1. By Value
      4. Base Editing
        1. By Value
      5. Prime Editing
        1. By Value
      6. Other Technologies
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. Contract Research organization
        1. By Value
      5. Other End Users
        1. By Value
    5. U.S.
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Product
          1. By Value
        3. Enzymes
          1. By Value
        4. Kits & Reagents
          1. By Value
        5. Guide RNA
          1. By Value
        6. CRISPR Libraries
          1. By Value
        7. Other Products
          1. By Value
        8. Service
          1. By Value
        9. gRNA Design & Synthesis
          1. By Value
        10. Cell Line Engineering
          1. By Value
        11. Animal Model Generation
          1. By Value
        12. CRISPR Screening Services
          1. By Value
        13. Other Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR/Cas9
          1. By Value
        3. CRISPR/Cas12
          1. By Value
        4. Base Editing
          1. By Value
        5. Prime Editing
          1. By Value
        6. Other Technologies
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. Contract Research organization
          1. By Value
        5. Other End Users
          1. By Value
    6. Canada
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Product
        1. By Value
      3. Enzymes
        1. By Value
      4. Kits & Reagents
        1. By Value
      5. Guide RNA
        1. By Value
      6. CRISPR Libraries
        1. By Value
      7. Other Products
        1. By Value
      8. Service
        1. By Value
      9. gRNA Design & Synthesis
        1. By Value
      10. Cell Line Engineering
        1. By Value
      11. Animal Model Generation
        1. By Value
      12. CRISPR Screening Services
        1. By Value
      13. Other Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR/Cas9
        1. By Value
      3. CRISPR/Cas12
        1. By Value
      4. Base Editing
        1. By Value
      5. Prime Editing
        1. By Value
      6. Other Technologies
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. Contract Research organization
        1. By Value
      5. Other End Users
        1. By Value
    5. U.K.
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Product
          1. By Value
        3. Enzymes
          1. By Value
        4. Kits & Reagents
          1. By Value
        5. Guide RNA
          1. By Value
        6. CRISPR Libraries
          1. By Value
        7. Other Products
          1. By Value
        8. Service
          1. By Value
        9. gRNA Design & Synthesis
          1. By Value
        10. Cell Line Engineering
          1. By Value
        11. Animal Model Generation
          1. By Value
        12. CRISPR Screening Services
          1. By Value
        13. Other Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR/Cas9
          1. By Value
        3. CRISPR/Cas12
          1. By Value
        4. Base Editing
          1. By Value
        5. Prime Editing
          1. By Value
        6. Other Technologies
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. Contract Research organization
          1. By Value
        5. Other End Users
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Product
        1. By Value
      3. Enzymes
        1. By Value
      4. Kits & Reagents
        1. By Value
      5. Guide RNA
        1. By Value
      6. CRISPR Libraries
        1. By Value
      7. Other Products
        1. By Value
      8. Service
        1. By Value
      9. gRNA Design & Synthesis
        1. By Value
      10. Cell Line Engineering
        1. By Value
      11. Animal Model Generation
        1. By Value
      12. CRISPR Screening Services
        1. By Value
      13. Other Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR/Cas9
        1. By Value
      3. CRISPR/Cas12
        1. By Value
      4. Base Editing
        1. By Value
      5. Prime Editing
        1. By Value
      6. Other Technologies
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. Contract Research organization
        1. By Value
      5. Other End Users
        1. By Value
    5. China
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Product
          1. By Value
        3. Enzymes
          1. By Value
        4. Kits & Reagents
          1. By Value
        5. Guide RNA
          1. By Value
        6. CRISPR Libraries
          1. By Value
        7. Other Products
          1. By Value
        8. Service
          1. By Value
        9. gRNA Design & Synthesis
          1. By Value
        10. Cell Line Engineering
          1. By Value
        11. Animal Model Generation
          1. By Value
        12. CRISPR Screening Services
          1. By Value
        13. Other Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR/Cas9
          1. By Value
        3. CRISPR/Cas12
          1. By Value
        4. Base Editing
          1. By Value
        5. Prime Editing
          1. By Value
        6. Other Technologies
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. Contract Research organization
          1. By Value
        5. Other End Users
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Product
        1. By Value
      3. Enzymes
        1. By Value
      4. Kits & Reagents
        1. By Value
      5. Guide RNA
        1. By Value
      6. CRISPR Libraries
        1. By Value
      7. Other Products
        1. By Value
      8. Service
        1. By Value
      9. gRNA Design & Synthesis
        1. By Value
      10. Cell Line Engineering
        1. By Value
      11. Animal Model Generation
        1. By Value
      12. CRISPR Screening Services
        1. By Value
      13. Other Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR/Cas9
        1. By Value
      3. CRISPR/Cas12
        1. By Value
      4. Base Editing
        1. By Value
      5. Prime Editing
        1. By Value
      6. Other Technologies
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. Contract Research organization
        1. By Value
      5. Other End Users
        1. By Value
    5. UAE
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Product
          1. By Value
        3. Enzymes
          1. By Value
        4. Kits & Reagents
          1. By Value
        5. Guide RNA
          1. By Value
        6. CRISPR Libraries
          1. By Value
        7. Other Products
          1. By Value
        8. Service
          1. By Value
        9. gRNA Design & Synthesis
          1. By Value
        10. Cell Line Engineering
          1. By Value
        11. Animal Model Generation
          1. By Value
        12. CRISPR Screening Services
          1. By Value
        13. Other Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR/Cas9
          1. By Value
        3. CRISPR/Cas12
          1. By Value
        4. Base Editing
          1. By Value
        5. Prime Editing
          1. By Value
        6. Other Technologies
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. Contract Research organization
          1. By Value
        5. Other End Users
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Product
        1. By Value
      3. Enzymes
        1. By Value
      4. Kits & Reagents
        1. By Value
      5. Guide RNA
        1. By Value
      6. CRISPR Libraries
        1. By Value
      7. Other Products
        1. By Value
      8. Service
        1. By Value
      9. gRNA Design & Synthesis
        1. By Value
      10. Cell Line Engineering
        1. By Value
      11. Animal Model Generation
        1. By Value
      12. CRISPR Screening Services
        1. By Value
      13. Other Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. CRISPR/Cas9
        1. By Value
      3. CRISPR/Cas12
        1. By Value
      4. Base Editing
        1. By Value
      5. Prime Editing
        1. By Value
      6. Other Technologies
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. Contract Research organization
        1. By Value
      5. Other End Users
        1. By Value
    5. Brazil
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Product
          1. By Value
        3. Enzymes
          1. By Value
        4. Kits & Reagents
          1. By Value
        5. Guide RNA
          1. By Value
        6. CRISPR Libraries
          1. By Value
        7. Other Products
          1. By Value
        8. Service
          1. By Value
        9. gRNA Design & Synthesis
          1. By Value
        10. Cell Line Engineering
          1. By Value
        11. Animal Model Generation
          1. By Value
        12. CRISPR Screening Services
          1. By Value
        13. Other Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. CRISPR/Cas9
          1. By Value
        3. CRISPR/Cas12
          1. By Value
        4. Base Editing
          1. By Value
        5. Prime Editing
          1. By Value
        6. Other Technologies
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. Contract Research organization
          1. By Value
        5. Other End Users
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. CRISPR Technology Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Agilent Technologies
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Beam Therapeutics
    3. Caribou Biosciences
    4. Cellecta
    5. CRISPR Therapeutics
    6. Danaher
    7. Editas Medicine
    8. ERS Genomics
    9. GenScript
    10. Integrated Micro-Biome Therapeutics
    11. Intellia Therapeutics
    12. Merck KGaA
    13. New England Biolabs
    14. Origene Technologies
    15. Precision Biosciences
    16. Revvity Inc
    17. Sangamo Therapeutics
    18. Synthego
    19. Takara Bio
    20. Thermo Fisher Scientific Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.